SURPASS-CVOT Results: How Does Tirzepatide Stack Up Against Dulaglutide for Cardiovascular Health? Published: December 17, 2025 | Source: New England Journal of Medicine Tirzepatide, the dual GIP and GLP-1 receptor agonist, has already made waves for its potent effects on … Read More
